Objectives The genotypic analysis of human metapneumo-(HMPV) and boca-(HBoV) viruses circulating in Greece and their comparison to reference and other clinical strains.
Introduction
Newly discovered viruses, such as human metapneumovirus (HMPV) and human bocavirus (HBoV) are important pathogens causing respiratory tract infection (RTI) in susceptible populations, particularly in children and the elderly. [1] [2] [3] [4] HMPV is a negative single stranded RNA virus belonging to the family of Paramyxoviridae, which was first isolated in 2001 5 from nasopharyngeal aspirates. It is responsible for about 5-15% of the worldwide respiratory tract infections, affecting both young children and adults, causing symptoms ranging from mild disease of the upper respiratory tract system to severe bronchiolitis and pneumonia. 2 In infants, HMPV incidence is even higher, reaching 25%. 6 Genetic analysis of HMPV isolates revealed two 'major' lineages (A and B) and four 'minor' lineages (A1, A2, B1 and B2), based on the sequence variability of the attachment (G) and fusion (F) surface glycoproteins. The existence of two further sublineages, A2a and A2b, has further been suggested. 7 HBoV, a single stranded DNA virus belonging to the family of Parvoviridae, was discovered in 2005 8 and has been detected in nasopharyngeal aspirates, sera and blood samples of patients with respiratory tract infection and in faecal specimens of patients with acute respiratory illness and/or gastroenteritis. HBoV affects, mostly, children younger than 2 years old, with its incidence ranging from 2Á7 to 19% in respiratory and from 0Á8 to 9Á1% in faecal samples, obtained from patients with respiratory infection and gastroenteritis, respectively. 9 Four species of HBoV have been recently discovered with HBoV1 being predominantly a respiratory pathogen, whereas HBoV2, HBoV3 and HBoV4 being found mainly in stool. 10 Nucleotide sequence analysis of the two capsid proteins (VP1 and VP2), which show high variability compared with coding sequences of the two viral nonstructural proteins (NS1 and NP1), has further divided HBoV1 into genotypes St1 and St2. These two major HBoV genotypes correspond to the original St1 (Stockholm 1) and St2 (Stockholm 2) isolates. 8 Epidemiological and phylogenetic analysis of HMPV and HBoV has been carried out extensively in other countries but not in Greece, where only a few studies concerning newly recognized respiratory viruses have been published. Using molecular methods for identification, we recently reported the incidence of 13 respiratory pathogens, including HMPV and HBoV, in children presenting with influenza-like illness (ILI). 11 In this study, we aimed to determine the genetic diversity of the HMPV and HBoV clinical strains identified within the Greek population by comparison with reference, as well as, wild strains described in other countries.
Patients and methods

Clinical specimens
Clinical specimens including nasopharyngeal aspirates and/ or throat swabs were collected over the winter seasons (November to May) of 2005/2006, 2006/2007 and 2007/2008 by paediatricians in healthcare units of Southern Greece and in collaborating paediatric hospitals of Athens. Specimens were sent to the National Influenza Reference Laboratory of Southern Greece in viral transport medium (Mediaproducts BV, Groningen, The Netherlands). Our sample group consisted in total of 3306 specimens from paediatric patients aged 0-18 years-old, 1272 out of whom suffered from ILI (sudden onset of symptoms, with high fever and cough in the absence of other diagnosis) and the remaining 2034 from other upper and lower respiratory tract infections which did not fall within the definition of ILI. The presence of HMPV RNA and HBoV DNA concerning patients with ILI has been described in our previous study. 11 In the present study, the same PCR protocols were used to reveal the presence of HMPV and HBoV in patients with other upper and lower respiratory tract infections (data not shown). Moreover, all specimens found negative for HBoV1 in our previous study 11 were further screened for the three recently identified species, HBoV2, HBoV3 and HBoV4, as previously described. 12 Nucleotide sequence analysis of HMPV and HBoV strains
In total, presence of HMPV RNA was detected in 188 (5Á7%) and HBoV DNA was detected in 193 (5Á8%) cases of the 3306 patients screened. Seven to ten positive specimens for either HMPV or HBoV belonging to each winter period (in total 50 samples) were further studied using specific primers mapping highly variable regions of the viral genome. The selected specimens amounting to 13% of total positive strains corresponded to the beginning (November-December), middle (January-February) and end (March-May) of each winter season. More specifically, 24 samples positive for HMPV were further amplified to obtain the genomic region corresponding to the 969 bp DNA fragment, encompassing the full-length of G protein coding region (240 amino acids). 13 Likewise, 26 samples positive for HBoV were amplified utilizing 4 overlapping sets of primers, spanning the whole length (672 amino acids) of the coding region corresponding to the VP1 and VP2 proteins (Table 1). 14 PCR products were purified using the QIAquick PCR purification kit (Qiagen, Hilden, Germany) and the MinEluteTM gel extraction kit (Qiagen) and subjected to direct sequencing in both directions utilizing the GenomeLab 
Phylogenetic analysis
Sequences obtained were examined in terms of closest homology sequence using BLAST software (http://www.ncbi. nlm.nih.gov/BLAST/). Multiple sequence alignments of representative strains identified in Europe, in addition to GenBank sequence data from original HMPV and HBoV prototype strains were made by BioEdit sequence alignment editor. Phylogenetic analysis of HMPV and HBoV-positive samples was performed using the molecular evolutionary genetics analysis (MEGA) software, version 5. 15 Phylogenetic trees were constructed by the neighbour-joining method (NJ, tree algorithm inferred with the Kimura 2-parameter substitution model of sequence evolution) 16, 17 while, a bootstrap resampling analysis was performed (1Á000 replicates) to test tree robustness. 18 Moreover, comparison of the mean sequence diversity in pairwise alignments was applied on both our strains and the representative prototypes. More specifically, the aligned sequences were compared using uncorrected p-distances (proportion of observed differences), handling gaps with complete deletion.
Nucleotide sequences accession numbers
All 50 sequences determined in the present report have been deposited in the GenBank/EMBL/DDBJ database under accession numbers JQ513461-JQ513510. The reference strains used in this study have been previously assigned with the following accession numbers: a) for the Netherlands HMPV prototypes AY296040 (NL/94/01), AY296034 (NL/1/ 99), AF371337 (NL/1/00), AY296021 (NL/00/17) b) for Stockholm HBoV prototypes DQ000495 (St1), DQ000496 (St2).
Results
Phylogenetic analysis of HMPV sequences
Twenty-four HMPV-positive samples, including 9 isolates detected in 2006, 8 detected in 2007 and 7 isolates detected in 2008, were characterized at the molecular level and a phylogenetic tree of the complete G gene was generated.
Comparison with the prototype strains from the Netherlands 13 revealed that all Greek-HMPV isolates clustered with NL/94/01 in genetic lineage B2 (Figure 1 ) and presented a nucleotide (nt) identity of 92Á0-100Á0% and an amino acid (aa) identity of 85Á9-100Á0% to each other.
Phylogenetic analysis of the studied strains classified them within 4 separate groups based on the number of aa differences they shared. More specifically, group 1 included HMPV strains that circulated during the first winter period and shared an aa substitution at position 238 (P238S), group 2 included strains which circulated during the second winter season and shared an aa substitution at position 200 (N200K) and group 3 included strains that circulated during the whole period under investigation and revealed 5 aa substitutions (D84Y, L105P, T166P, E190K and S198P). Concerning group 4, sequence alignment revealed the insertion of 2 additional amino acids in specimen 1106/08 (one Lys and one Glu) and 4 amino acids in specimen 181/07 (two Lys and two Glu). These two HMPV strains also shared a number of amino acid substitutions in relation to all the other Greek specimens analysed in this study (Figure 2) . Intergroup analysis exposed 4 aa substitutions between groups 2 and 3 (I22L, E63D, D208N and A213T), 7 aa substitutions between groups 1, 2 and 3 (T39S, L56S, Q93R, S109L, T149A, G155R and P220S) and 1 aa substitution between groups 1, 3 and 4 (D111G/N). Comparing the Greek strains with the HMPV B2 reference sequence, they all shared 8 aa substitutions throughout the whole G protein (M55T/K, A98T, A99T, Y133H/R, Y187N/K, V188G/R, S201N/G, H221Q/Y).
To summarize, sequencing analysis suggested that among HMPV strains, only those belonging to group 3 circulated throughout the whole period under study. Intragroup analysis within group 3 also suggested specific variations within the strains that circulated during each winter season. (Figure 3) . The remaining 2 (7Á7%) strains studied, HBoVs/Athens.GRC/35.07 and HBoVs/Athens.GRC/108.07, which clustered neither with St1 nor with St2 genotype, formed a third group which shared 98Á2-98Á5% nt identity with St1 and 98Á4-98Á7% nt identity with St2. All of the Greek strains showed an nt identity of 98Á2-100Á0% and a deduced aa identity of 95Á6-100Á0% with each other and appeared to be most closely related to the Tunisian (TUN2207) and the Chinese (CQ201102) strains.
More specifically, for specimens belonging to St1 and St2 groups, analysis of intra-and intergenotype nt and aa sequences revealed different levels of homology. When comparing strains belonging to the above genotypes (19 different strains), diversity at the nt level varied between 0Á05 and 0Á99% and at the aa level between 0Á15 and 0Á45%. When comparing only the two St1 strains, diversity at the nt level was 0Á55% and at the aa level was 0Á15%. Likewise, for St2 strains (17 different strains), the highest divergence was up to 0Á55% at the nt and 0Á3% at the aa level.
Interestingly, 5 aa substitutions were observed in both strains belonging to the third HBoV group and included L40S, A340P, G415S, T521N and F540Y while three additional mutations (P430L, L433F and P541L) were revealed in the strain HBoVs/Athens.GRC/108.07. The boot scanning analysis suggested that the strains HBoVs/Athens.GRC/35.07 and HBoVs/Athens.GRC/108.07 resulted from recombination between a HBoVs/Athens.GRC/27.07-like and a HBoVs/Athens.GRC/24.08-like strain (belonging to St1 group), with a breakpoint located at position 1260 bp of the complete VP1/VP2 region (Figure 4 ). Bidirectional sequencing, as well as, the fact that the recombination breakpoint was located within the 3rd amplicon of VP1/VP2 region suggested that this result was not due to mixed infection.
In conclusion, sequencing data suggested that at least 3 groups of HBoV cocirculated in Southern Greece during the study period. Similar observations were also made by Chieochansin et al., 14 Lin et al 19 and Xu et al. 20 In each of the above study populations, including ours, the representative strain of group 1 and group 2 was the prototype strains St1 and St2, respectively. The Greek strains, which clustered within group 1, were found to share a common aa substitution at position 590 (S590T, with respect to VP1 numbering) with all the St1 reference strains used in the phylogenetic analysis, compared with group 2 (Figure 3) , an observation also made by others. 14 35, 36 As year-round surveillance was not performed and summer infections from HMPV and HBoV cannot be excluded, recirculation of the same HMPV lineage over three consecutive years within the Greek population could be the result of the maintenance of the virus throughout the year. Alternatively, HMPV lineage B2 could have been 38, 39 and in different HBoV species. [40] [41] [42] Our data suggest that the strains HBoVs/ Athens.GRC/35.07 and HBoVs/Athens.GRC/108.07 resulted from recombination events between a HBoVs/Athens.GRC/ 27.07-like and a HBoVs/Athens.GRC/24.08-like strains, with a breakpoint site in the VP1/VP2 region. To date, similar intraspecies recombination events involving HBoV1 have been reported before, with a breakpoint located in the NS1, 19 VP1/VP2 21 and NS1 and VP1/VP2 20 regions. Taken together, these data suggest that intraspecies recombination could occur in HBoV1 at different positions of its genome. Further studies, including whole genome sequencing, are necessary to identify breakpoint patterns in these viruses, thus exploring their potential association with viral spread among populations.
Higher similarity observed between HBoV sequences to that observed between HMPV strains may be explained by the widespread assumption that mutation rates correspond to the fidelity of replication. DNA viruses, such as HBoV, mutate slower compared with RNA viruses, such as HMPV, because DNA polymerases possess proof-reading activity, which further reduces mutation rates during DNA replication. 43 Moreover, the rate of generation and correction of genomic mutations may depend on a number of factors, including generation time, genomic architecture, replication speed, transmission and environmental effects.
Our study highlighted the heterogeneity of viral strains circulating within the Greek population by determination of the complete sequences of HMPV G gene and HBoV VP1/ VP2 gene. The phylogenetic analysis performed aimed to monitor the genetic evolution of HMPV and HBoV during three consecutive years and revealed an individual predominant lineage for the former and a combination of genotypes for the latter.
